Get started
Author

Nina Bhardwaj

A Tumor-Promoting Inflammatory SPP1 + Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al. · Cancer Discovery · 16
PDF
Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer
2026 · Guillaume Mestrallet, Matthew Brown, et al. · Cell Reports Medicine · 9
Pipe dream to pipeline: Journey of cancer vaccines and the road ahead
2026 · Sayali Onkar, Cansu Cimen Bozkus, et al. · Cell Reports Medicine · 6
Abstract C069: Leveraging cDC1 populations for enhanced mRNA cancer vaccination
2026 · Ross Ward, Aparna Anantharayanan, et al. · Cancer Immunology Research · 1
Abstract 6787: Metabolic reuse of tumor-derived signals coordinates dendritic cell function
2026 · Meriem Belabed, Chang Y. Moon, et al. · Cancer Research
Abstract LB-B009: Design and immunogenicity of sequential cancer vaccination targeting shared tumor-associated antigens and personalized neoantigens in a single patient with uterine leiomyosarcoma
2026 · Mansi Saxena, Cansu Cimen Bozkus, et al. · Cancer Immunology Research
A tumor-promoting inflammatory SPP1⁺ macrophage–IL-6–CRP axis drives immune dysfunction in bladder cancer
2026 · Tran, Michelle, Cho, Byuri Angela, et al. · Zenodo (CERN European Organization for Nuclear Research)
Abstract B060: CMV-induced adaptive NK cell functions to improve bladder cancer patient outcomes
2026 · Bérengère Salomé, Igor Duquesne, et al. · Cancer Immunology Research
Works count: 8
Citation count: 32
H-index: 3
I10-index: 1
Year
Topic
Type